Anteris Technologies Global (AVR) Stock Price, News & Analysis

Company Overview

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Key Stats

• Today's Range: $4.21 to $4.60
• 50-Day Range: $2.47 to $7.98
• 52-Week Range: $2.34 to $8.79
• Volume: 79,739 shs
• Average Volume: 213,081 shs
• Market Capitalization: $151.82 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $16.50
• Consensus Rating: Buy

AVR Stock Analysis - Frequently Asked Questions

How have AVR shares performed this year?

Anteris Technologies Global's stock was trading at $5.58 at the beginning of the year. Since then, AVR stock has decreased by 24.6% and is now trading at $4.21.
View the best growth stocks for 2025 here.

When did Anteris Technologies Global IPO?

Anteris Technologies Global (AVR) raised $89 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.00 per share.

When does the company's lock-up period expire?

Anteris Technologies Global's lock-up period expires on Wednesday, June 11th. Anteris Technologies Global had issued 14,800,000 shares in its IPO on December 13th. The total size of the offering was $88,800,000 based on an initial share price of $6.00. After the end of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

Who are Anteris Technologies Global's major shareholders?

Top institutional shareholders of Anteris Technologies Global include Charles Schwab Investment Management Inc. (0.10%), Wellington Shields & Co. LLC (0.07%), Bank of New York Mellon Corp (0.07%) and Deutsche Bank AG (0.04%).

How do I buy shares of Anteris Technologies Global?

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 5/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical appliances & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AVR
• Previous Symbol: NASDAQ:AVR
• CIK: 2011514
• Web: N/A
• Phone: (651) 493-0606
• Fax: N/A
• Employees: 138
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $16.50
• High Stock Price Target: $22.00
• Low Stock Price Target: $9.00
• Potential Upside/Downside: +291.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $2.71 million
• Price / Sales: 56.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 36,062,000
• Free Float: N/A
• Market Cap: $151.82 million
• Optionable: N/A
• Beta: N/A